A detailed history of Legacy Financial Strategies, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Legacy Financial Strategies, LLC holds 18,551 shares of ABBV stock, worth $3.3 Million. This represents 0.82% of its overall portfolio holdings.

Number of Shares
18,551
Previous 18,484 0.36%
Holding current value
$3.3 Million
Previous $3.17 Million 15.55%
% of portfolio
0.82%
Previous 0.78%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

BUY
$163.84 - $199.33 $10,977 - $13,355
67 Added 0.36%
18,551 $3.66 Million
Q2 2024

Jul 10, 2024

BUY
$154.79 - $180.76 $271,811 - $317,414
1,756 Added 10.5%
18,484 $3.17 Million
Q1 2024

Apr 10, 2024

BUY
$159.82 - $182.1 $99,088 - $112,902
620 Added 3.85%
16,728 $3.05 Million
Q4 2023

Feb 01, 2024

BUY
$137.6 - $154.97 $6,054 - $6,818
44 Added 0.27%
16,108 $2.5 Million
Q3 2023

Nov 13, 2023

BUY
$133.59 - $154.65 $79,753 - $92,326
597 Added 3.86%
16,064 $2.39 Million
Q2 2023

Jul 28, 2023

BUY
$132.51 - $164.9 $198,367 - $246,855
1,497 Added 10.72%
15,467 $2.08 Million
Q1 2023

May 10, 2023

BUY
$144.61 - $166.54 $125,521 - $144,556
868 Added 6.62%
13,970 $2.23 Million
Q4 2022

Feb 15, 2023

BUY
$138.31 - $165.87 $121,989 - $146,297
882 Added 7.22%
13,102 $2.12 Million
Q3 2022

Nov 08, 2022

SELL
$134.21 - $153.93 $218,896 - $251,059
-1,631 Reduced 11.78%
12,220 $1.64 Million
Q2 2022

Aug 09, 2022

BUY
$137.62 - $174.96 $69,635 - $88,529
506 Added 3.79%
13,851 $2.12 Million
Q1 2022

May 06, 2022

SELL
$131.98 - $163.75 $14,517 - $18,012
-110 Reduced 0.82%
13,345 $2.16 Million
Q4 2021

Jan 31, 2022

BUY
$107.43 - $135.93 $45,120 - $57,090
420 Added 3.22%
13,455 $1.82 Million
Q3 2021

Nov 15, 2021

BUY
$106.4 - $120.78 $94,483 - $107,252
888 Added 7.31%
13,035 $1.41 Million
Q2 2021

Aug 02, 2021

BUY
$105.21 - $117.21 $75,330 - $83,922
716 Added 6.26%
12,147 $1.37 Million
Q1 2021

May 07, 2021

BUY
$102.3 - $112.62 $55,446 - $61,040
542 Added 4.98%
11,431 $1.24 Million
Q4 2020

Feb 04, 2021

BUY
$80.49 - $108.67 $19,800 - $26,732
246 Added 2.31%
10,889 $1.17 Million
Q3 2020

Nov 03, 2020

BUY
$85.91 - $100.83 $18,642 - $21,880
217 Added 2.08%
10,643 $932,000
Q2 2020

Aug 14, 2020

BUY
$73.37 - $98.18 $20,983 - $28,079
286 Added 2.82%
10,426 $1.02 Million
Q1 2020

May 04, 2020

BUY
$64.5 - $97.79 $61,920 - $93,878
960 Added 10.46%
10,140 $773,000
Q4 2019

Jan 27, 2020

BUY
$72.13 - $90.25 $64,772 - $81,044
898 Added 10.84%
9,180 $813,000
Q3 2019

Nov 01, 2019

BUY
$62.98 - $75.72 $59,642 - $71,706
947 Added 12.91%
8,282 $649,000
Q2 2019

Jul 15, 2019

BUY
$65.7 - $83.98 $35,149 - $44,929
535 Added 7.87%
7,335 $523,000
Q1 2019

May 08, 2019

BUY
$77.14 - $90.79 $45,358 - $53,384
588 Added 9.47%
6,800 $548,000
Q4 2018

Feb 15, 2019

BUY
$77.85 - $96.01 $22,498 - $27,746
289 Added 4.88%
6,212 $573,000
Q3 2018

Nov 14, 2018

BUY
$88.91 - $98.84 $11,113 - $12,355
125 Added 2.16%
5,923 $522,000
Q2 2018

Aug 14, 2018

BUY
$89.78 - $106.23 $14,185 - $16,784
158 Added 2.8%
5,798 $537,000
Q1 2018

May 14, 2018

SELL
$92.01 - $123.21 $4,876 - $6,530
-53 Reduced 0.93%
5,640 $534,000
Q4 2017

May 14, 2018

BUY
$89.56 - $98.21 $509,865 - $559,109
5,693
5,693 $551,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $315B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Legacy Financial Strategies, LLC Portfolio

Follow Legacy Financial Strategies, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legacy Financial Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Legacy Financial Strategies, LLC with notifications on news.